Table 3.
Risk groups | Event (%) | Hazard ration | p value |
---|---|---|---|
MELD score | |||
≤ 20 | 31 (22.10) | 1 | – |
> 20 | 109 (40.20) | 2.321 (1.557–3.460) | < 0.001 |
MELD-Na score | |||
< 25 | 58 (41.40) | 1 | - |
≥ 25 | 82 (58.60) | 2.876 (2.053–4.028) | < 0.001 |
Sarcopenia | |||
No | 25 (17.90) | 1 | – |
Yes | 115 (82.10) | 3.119 (2.505–6.771) | < 0.001 |
AMPAS1 | |||
< 0.31 | 29 (20.6) | 1 | – |
≥ 0.31 | 111 (79.4) | 7.523 (4.591–12.327) | < 0.001 |
Hazard ratios from univariable Cox proportional hazard regression for prediction of 90 day progressive events according to low- and high-risk patients, with P values for between-group differences shown as hazard ratios. We used previously published cut-off points to define the risk groups
MELD score, End-stage Liver Disease score; MELD-Na, End-stage Liver Disease includes serum sodium score; AMPAS1, including age, MELD score, platelet, AFP, sarcopenia, and more than one complication